Selegiline and mortality in Parkinson's disease.
Olanow
C W
CW
Department of Neurology, Mount Sinai Medical Center, New York, NY 10029, USA.
Fahn
S
S
Langston
J W
JW
Godbold
J
J
D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D010300:Parkinson Disease / Q000188:drug therapy* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D012642:Selegiline / Q000008:administration & dosage*
D012642:Selegiline; D007980:Levodopa